Novartis AG Payments To Acquire Or Redeem Entitys Shares
Novartis AG (NVS) reported Payments To Acquire Or Redeem Entitys Shares of $9.21 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:PaymentsToAcquireOrRedeemEntitysShares · last filed 2026-02-04
- Novartis AG payments to acquire or redeem entitys shares for the quarter ending 2025-06-30 was $2.71B, a 67.95% increase year-over-year.
- Novartis AG payments to acquire or redeem entitys shares for the quarter ending 2024-06-30 was $1.62B, a 45.35% decline year-over-year.
- Novartis AG payments to acquire or redeem entitys shares for the quarter ending 2023-06-30 was $2.96B, a 8.95% increase year-over-year.
- Novartis AG payments to acquire or redeem entitys shares for the quarter ending 2022-06-30 was $2.71B, a 286.06% increase year-over-year.
| Period end | Payments To Acquire Or Redeem Entitys Shares 3 month | Payments To Acquire Or Redeem Entitys Shares 6 month | Payments To Acquire Or Redeem Entitys Shares 12 month |
|---|---|---|---|
| 2025-12-31 | $9.21B 20-F · filed 2026-02-04 | ||
| 2025-06-30 | $2.71B 6-K · filed 2025-07-17 | $5.43B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $8.33B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | $1.62B 6-K · filed 2025-07-17 | $2.71B 6-K · filed 2025-07-17 | |
| 2023-12-31 | $8.72B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $2.96B 6-K · filed 2024-07-18 | $5.84B 6-K · filed 2024-07-18 | |
| 2022-12-31 | $10.65B 20-F · filed 2025-01-31 | ||
| 2022-06-30 | $2.71B 6-K · filed 2023-07-18 | $5.26B 6-K · filed 2023-07-18 | |
| 2021-12-31 | $3.06B 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $703.00M 6-K · filed 2022-07-19 | $2.63B 6-K · filed 2022-07-19 | |
| 2020-12-31 | $2.84B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $9.00M 6-K · filed 2021-07-21 | $150.00M 6-K · filed 2021-07-21 | |
| 2019-12-31 | $5.53B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $2.37B 6-K · filed 2020-07-21 | $2.59B 6-K · filed 2020-07-21 | |
| 2018-12-31 | $2.04B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $599.00M 6-K · filed 2019-07-18 | $774.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | $5.49B 20-F · filed 2020-01-29 | ||
| 2017-06-30 | $1.88B 6-K · filed 2018-07-18 | $3.17B 6-K · filed 2018-07-18 | |
| 2016-12-31 | $1.11B 20-F · filed 2019-01-30 | ||
| 2015-12-31 | $6.07B 6-K · filed 2018-01-24 |